HealthEquity Inventory 2014-2025 | HQY

HealthEquity inventory from 2014 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
  • HealthEquity inventory for the quarter ending January 31, 2025 was $0M, a 0% increase year-over-year.
  • HealthEquity inventory for 2025 was $0B, a 0% decline from 2024.
  • HealthEquity inventory for 2024 was $0B, a 0% decline from 2023.
  • HealthEquity inventory for 2023 was $0B, a 0% decline from 2022.
HealthEquity Annual Inventory
(Millions of US $)
2025 $0
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $1
2016 $1
2015 $1
2014 $0
2013 $0
HealthEquity Quarterly Inventory
(Millions of US $)
2025-01-31
2024-10-31
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
2020-04-30
2020-01-31
2019-10-31
2019-07-31
2019-04-30
2019-01-31
2018-10-31 $0
2018-07-31 $0
2018-04-30 $0
2018-01-31
2017-10-31 $0
2017-07-31 $0
2017-04-30 $1
2017-01-31 $1
2016-10-31 $1
2016-07-31 $1
2016-04-30 $1
2016-01-31 $1
2015-10-31 $1
2015-07-31 $1
2015-04-30 $1
2015-01-31 $1
2014-10-31 $1
2014-07-31 $0
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-01-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $7.819B $1.200B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.784B 25.47
Elevance Health (ELV) United States $91.409B 11.80
CVS Health (CVS) United States $84.718B 10.53
Cencora (COR) United States $54.879B 19.08
DiDi Global (DIDIY) China $20.661B 31.36
Natera (NTRA) United States $20.542B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.150B 12.86
EUROFINS SCIENT (ERFSF) Luxembourg $11.973B 0.00
Doximity (DOCS) United States $11.050B 57.47
CochLear (CHEOY) Australia $10.944B 0.00
ICON (ICLR) Ireland $10.818B 10.06
Revvity (RVTY) United States $10.756B 18.51
Viatris (VTRS) United States $10.400B 3.54
Medpace Holdings (MEDP) United States $8.508B 22.60
Sonic Healthcare (SKHHY) Australia $8.280B 0.00
Avantor (AVTR) United States $8.191B 11.90
Charles River Laboratories (CRL) United States $6.817B 13.36
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $3.982B 23.48
BrightSpring Health Services (BTSG) United States $3.976B 36.81
Sotera Health (SHC) United States $3.727B 21.18
Alignment Healthcare (ALHC) United States $2.991B 0.00
Surgery Partners (SGRY) United States $2.841B 32.59
Concentras Parent (CON) United States $2.743B 15.85
Organon (OGN) United States $2.264B 2.41
Premier (PINC) United States $2.106B 14.42
Ardent Health Partners (ARDT) United States $2.073B 8.85
Progyny (PGNY) United States $1.815B 39.98
GeneDx Holdings (WGS) United States $1.660B 64.99
GoodRx Holdings (GDRX) United States $1.657B 30.86
PACS (PACS) United States $1.590B 0.00
Pediatrix Medical (MD) United States $1.248B 9.50
Teladoc Health (TDOC) United States $1.247B 0.00
Agilon Health (AGL) United States $1.196B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.978B 0.00
CareDx (CDNA) United States $0.855B 13.36
AMN Healthcare Services Inc (AMN) United States $0.840B 7.89
Embecta (EMBC) United States $0.696B 4.71
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.667B 13.08
Enhabit (EHAB) United States $0.521B 42.83
Auna S.A (AUNA) Luxembourg $0.508B 13.45
InnovAge Holding (INNV) United States $0.491B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
LifeMD (LFMD) United States $0.375B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.352B 0.00
SBC Medicals (SBC) United States $0.345B 0.00
Beauty Health (SKIN) United States $0.234B 0.00
Oncology Institute (TOI) United States $0.212B 0.00
Performant Healthcare (PHLT) United States $0.195B 0.00
DocGo (DCGO) United States $0.143B 23.33
Basel Medical Group (BMGL) Singapore $0.088B 0.00
So-Young (SY) China $0.086B 0.00
Sera Prognostics (SERA) United States $0.084B 0.00
OncoCyte (OCX) United States $0.082B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.054B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
KindlyMD (KDLY) United States $0.023B 0.00
ModivCare (MODV) United States $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00